BMC cancer
Biomarker study on pneumonitis in durvalumab maintenance therapy after chemoradiotherapy for stage III non-small cell lung cancer.
Ryo Yano, Takaaki Tokito, Kenta Murotani, Daiki Murata, Shingo Tsuneyoshi, Hidenobu Ishii, Koichi Azuma, Tomoaki Hoshino
Published: 202510.1186/s12885-025-15467-0
No abstract available for this study.